Swiss Re (VTX:SREN)‘s stock had its “buy” rating reaffirmed by equities researchers at Deutsche Bank in a research note issued to investors on Friday.
SREN has been the subject of several other reports. HSBC set a CHF 107 target price on shares of Swiss Re and gave the stock a “buy” rating in a report on Friday, January 19th. Jefferies Group set a CHF 89 target price on shares of Swiss Re and gave the stock a “neutral” rating in a report on Tuesday, November 28th. Citigroup set a CHF 88 target price on shares of Swiss Re and gave the stock a “neutral” rating in a report on Friday, January 12th. DZ Bank reaffirmed a “buy” rating on shares of Swiss Re in a report on Tuesday, January 16th. Finally, UBS Group set a CHF 84 target price on shares of Swiss Re and gave the stock a “sell” rating in a report on Friday, January 5th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the company’s stock. Swiss Re currently has an average rating of “Hold” and an average target price of CHF 96.62.
Shares of Swiss Re (VTX SREN) traded up CHF 0.14 during midday trading on Friday, reaching CHF 92.20. 3,550,000 shares of the company were exchanged, compared to its average volume of 1,730,000. Swiss Re has a one year low of CHF 81.65 and a one year high of CHF 95.72. The stock has a market cap of $31,960.00 and a PE ratio of 12.07.
Swiss Re Company Profile
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.